In The News

Ropes & Gray Represents Galderma in Sale of Alchemee (formerly The Proactiv Company) to Taro Pharmaceutical

Practices: Mergers & Acquisitions, Capital Markets, Securities & Public Companies, Life Sciences, Health Care, Tax, Litigation, Executive Compensation & Employee Benefits

Ropes & Gray advised Switzerland-based Galderma in an agreement for Taro Pharmaceutical Industries to acquire Alchemee, formerly The Proactiv Company, from Galderma, a leading independent dermatology company. The agreement between Galderma and Taro includes Alchemee’s business and assets worldwide, including the Proactiv brand. 

Skin care product Proactiv is a leading consumer acne brand used by millions worldwide for more than 25 years. The deal was announced on February 22. Financial terms were not disclosed. 

The Ropes & Gray team was led by mergers & acquisitions counsel Sarah Davis and partner Zach Blume (both of Boston) and included IP transactions partner Hannah England (Freeman) (Boston), tax partner Elaine Murphy and counsel Michael Mendelevich (both of Boston), employment & benefits partners Loretta Richard and Jen Cormier (both of Boston), litigation & enforcement partners Brendan Hanifin (Chicago) and Samer Musallam (Washington, D.C.), health care partner Kellie Combs (Washington, D.C.), private equity partner Neill Jakobe (Chicago), health care counsel Alison Fethke (Chicago), data, privacy & cybersecurity counsel Kevin Angle (Boston), litigation & enforcement counsel Deidre Johnson and Steve Kaye (both of Boston) and mergers & acquisitions associates Asiya Ubaid (New York) and Kelley Cohen, Ryan McCaffrey and Kasey McNamara (all of Boston).

Cookie Settings